about
Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cellsCyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrestCyclin G2 promotes hypoxia-driven local invasion of glioblastoma by orchestrating cytoskeletal dynamics.Nanostructural and transcriptomic analyses of human saliva derived exosomes.Effects of smoking cessation on gene expression in human leukocytes of chronic smokerMicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancerDown-regulation of cyclin G2 by insulin, IGF-I (insulin-like growth factor 1) and X10 (AspB10 insulin): role in mitogenesis.Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencingThe nuclear receptor constitutive active/androstane receptor arrests DNA-damaged human hepatocellular carcinoma Huh7 cells at the G2/M phase.Drosophila Cyclin G Is a Regulator of the Notch Signalling Pathway during Wing DevelopmentElevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.Cyclin G2: A novel independent prognostic marker in pancreatic cancer.Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells.Overexpression of RNA-binding protein CELF1 prevents apoptosis and destabilizes pro-apoptotic mRNAs in oral cancer cells.Cyclins and cell cycle control in cancer and disease.HIF-1alpha and HIF-2alpha have divergent roles in colon cancer.Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signalingComprehensive phenotypic analysis of knockout mice deficient in cyclin G1 and cyclin G2.Proteomics revisits the cancer metabolome.ELAS1-mediated inhibition of the cyclin G1-B'γ interaction promotes cancer cell apoptosis via stabilization and activation of p53.CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance.Changes in the expression of cyclin G2 in esophageal cancer cell and its significance.Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell.Change in expression of cyclin G2 in kidney cancer cell and its significance.Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma.Recruitment of cyclin G2 to promyelocytic leukemia nuclear bodies promotes dephosphorylation of γH2AX following treatment with ionizing radiation.Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.Mast cells dysregulate apoptotic and cell cycle genes in mucosal squamous cell carcinoma.Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival.The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells.CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells.Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt SignallingmiR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas
P2860
Q24300910-46E9E980-9DE4-4138-8306-39030404E518Q24646831-39A3E46F-D469-4768-8D48-A9D02085235CQ24675495-A9C04B42-BB3C-4A18-9411-5B0AD94EC199Q30009513-E25644A8-BE5F-4157-AB80-3C56824BAF88Q33522242-9F7419BC-D6EE-45CE-B831-42A4B4B6CC91Q34012242-C16E98CD-70EE-4719-812A-BFCCDFD09D08Q34354587-01676F29-DFA2-4719-AA9D-9B72FCBFA328Q34372865-566027FC-6E29-420A-9CE8-B68CB536D826Q35153783-C8BAB41D-EBA7-4D0C-B346-394EEEE68CA7Q35624247-FDD79F9F-72CC-4FFC-B7E7-1671B0A314D4Q35952518-E5FE20AF-7DFB-428F-A340-CBC5195054AEQ36080515-F6C820FB-3AD0-48D7-A6D3-CDA6BC454E58Q36335693-E38A911C-9FCB-48C8-8FC5-87C54002B7E8Q36412542-21E66055-759D-4A42-A5ED-42D9946E3BD9Q36674383-A449E6FB-4DF3-44BD-BEC9-A75B85AE4D63Q36796438-B904839B-BD05-4E41-99E7-255DBD8E4F03Q37192848-1809435C-81C0-423C-B45D-587968F8B6F5Q37257711-BDC0B9C8-DAF8-4E8C-99EB-1FB7929FC3E5Q37508344-F9B17CCA-911B-407F-8B16-1610788FC27DQ37912205-DD8D1327-C518-49CA-BC27-D2C7A1FFD2DCQ38881935-E3CCB5A8-C3B6-41F4-8FDB-0BD2EA7824C2Q39048478-AA570DBA-DC98-431C-8C5A-0C3B2DD41866Q39050988-AFF58186-674F-4FF5-91C6-8393E26ED6D0Q39051459-F15723B8-DF35-47C4-B1E9-5877BCB1056AQ39056123-CC789269-1C42-484F-88F1-AB57D324B59FQ39061594-800AEA1E-6A33-44C3-810C-EAA1ED0C2BE3Q39154755-E9138CBB-CE89-48AA-AB79-99814E273878Q39489732-B86977F1-73F0-4735-BBB3-A7F90AB6A7D5Q40193455-F4473DBA-811E-417C-9BF1-74E14EF774C9Q42345385-A470EE09-15CB-4222-A749-2F80F2B6492BQ52659598-639BD7BD-9601-4A34-A09E-D23A16ED6F0AQ54979866-C93615C6-6B70-4551-A5AE-8050B73D75BBQ58695035-88CA7287-24A7-4C2F-A096-53187A8AD31CQ58773180-6E814A10-B425-4E3C-B26D-98D4BC8FFE53
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cyclin G2 dysregulation in human oral cancer.
@ast
Cyclin G2 dysregulation in human oral cancer.
@en
type
label
Cyclin G2 dysregulation in human oral cancer.
@ast
Cyclin G2 dysregulation in human oral cancer.
@en
prefLabel
Cyclin G2 dysregulation in human oral cancer.
@ast
Cyclin G2 dysregulation in human oral cancer.
@en
P2093
P1433
P1476
Cyclin G2 dysregulation in human oral cancer.
@en
P2093
David T Wong
Rong Zhang
Satoru Shintani
Yohko Kohno
P304
P356
10.1158/0008-5472.CAN-04-1926
P407
P577
2004-12-01T00:00:00Z